当前位置:首页 - 行情中心 - 红日药业(300026) - 财务分析 - 现金流量表

红日药业

(300026)

  

流通市值:93.34亿  总市值:93.43亿
流通股本:30.01亿   总股本:30.04亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,908,806,212.422,625,008,824.751,258,058,257.465,715,513,731.45
  收到的税费返还16,051,224.477,426,960.413,868,638.0238,191,947.26
  收到其他与经营活动有关的现金85,152,558.9455,869,927.7133,364,931.2263,549,213.32
  经营活动现金流入小计4,010,009,995.832,688,305,712.871,295,291,826.75,817,254,892.03
  购买商品、接受劳务支付的现金1,319,957,905.83796,880,813.76417,972,809.681,831,632,871.12
  支付给职工以及为职工支付的现金650,546,690.63452,173,023.82251,039,051.95875,668,988.54
  支付的各项税费325,946,380.29247,834,871.77130,197,089.28490,180,770.97
  支付其他与经营活动有关的现金1,218,961,503.14833,325,562.19404,704,418.471,808,430,650.61
  经营活动现金流出小计3,515,412,479.892,330,214,271.541,203,913,369.385,005,913,281.24
  经营活动产生的现金流量净额494,597,515.94358,091,441.3391,378,457.32811,341,610.79
二、投资活动产生的现金流量:
  收回投资收到的现金---661,091.33
  处置固定资产、无形资产和其他长期资产收回的现金净额4,211,713.35324,690.428,728.3703,899.49
  处置子公司及其他营业单位收到的现金净额16,534,460.7616,544,197.04--
  收到的其他与投资活动有关的现金---1,540,000
  投资活动现金流入小计20,746,174.1116,868,887.468,728.32,904,990.82
  购建固定资产、无形资产和其他长期资产支付的现金75,496,284.9347,954,717.3628,836,828.69130,249,796.03
  支付其他与投资活动有关的现金5,112.361.29--
  投资活动现金流出小计75,501,397.2947,954,718.6528,836,828.69130,249,796.03
  投资活动产生的现金流量净额-54,755,223.18-31,085,831.19-28,828,100.39-127,344,805.21
三、筹资活动产生的现金流量:
  取得借款收到的现金83,429,052.0283,429,052.02794,748.8955,331,629.05
  收到其他与筹资活动有关的现金6,302,431.69---
  筹资活动现金流入小计89,731,483.7183,429,052.02794,748.8955,331,629.05
  偿还债务支付的现金235,480,814.73224,053,881.3311,338,600352,520,132.77
  分配股利、利润或偿付利息支付的现金46,076,933.628,706,417.875,995,789.4122,973,706.96
  其中:子公司支付给少数股东的股利、利润9,497,074.53,136,0003,136,00017,575,913.21
  支付其他与筹资活动有关的现金30,008,964.522,285,798.2215,083,160.349,850,103.33
  筹资活动现金流出小计311,566,712.85255,046,097.4232,417,549.7525,343,943.06
  筹资活动产生的现金流量净额-221,835,229.14-171,617,045.4-31,622,800.81-470,012,314.01
四、汇率变动对现金及现金等价物的影响-12,052,275.98-8,905,897.85-4,993,071.72-3,456,522.37
五、现金及现金等价物净增加额205,954,787.64146,482,666.8925,934,484.4210,527,969.2
  加:期初现金及现金等价物余额1,483,651,060.81,483,651,060.81,483,651,060.81,273,123,091.6
  期末现金及现金等价物余额1,689,605,848.441,630,133,727.691,509,585,545.21,483,651,060.8
补充资料:
  净利润-82,910,766.17-22,223,495.61
  资产减值准备-26,146,896.21-238,528,350.71
  固定资产和投资性房地产折旧-120,613,685.85-247,900,563.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-120,613,685.85-247,900,563.9
  无形资产摊销-16,657,147.61-34,361,030.65
  长期待摊费用摊销-8,450,561.67-27,921,084.53
  处置固定资产、无形资产和其他长期资产的损失--11,039.76--702,535.55
  固定资产报废损失-959,483.87-1,248,282.67
  财务费用-11,933,312.33-25,374,703.59
  投资损失-10,776,202.06-3,658,808.4
  递延所得税--13,920,771.74--9,484,132.68
  其中:递延所得税资产减少--11,955,389.75--1,238,114.57
    递延所得税负债增加--1,965,381.99--8,246,018.11
  存货的减少--7,185,876.56-255,248,103.48
  经营性应收项目的减少-68,521,884.76-252,022,267.38
  经营性应付项目的增加-9,026,890.64--329,863,767.03
  其他--5,641,927.24--6,021,944.1
  现金的期末余额-1,630,133,727.69-1,483,651,060.8
  减:现金的期初余额-1,483,651,060.8-1,273,123,091.6
  现金及现金等价物的净增加额-146,482,666.89-210,527,969.2
公告日期2026-10-302026-08-262026-04-292026-04-21
审计意见(境内)标准无保留意见
TOP↑